Researchers developed a nasal antibody that blocks mugwort pollen, a major hay fever trigger in Europe and Central Asia.

Discover how Agilent's AssayMAP Bravo and RapidFire systems accelerate drug discovery with automation and rapid, reliable ...

At ASMS 2025, the Technology Networks team spoke with Chris Lock from SCIEX to discuss how improvements in proteomics ...

How concerned should we be about PFAS in our drinking water? Professor Rainer Lohmann answers this question and more.

Researchers have identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often used in ...

Technology Networks spoke with Stefan Foser, vice president of global pharma at Bruker, to explore how they integrate ...

A Weizmann Institute study has identified hundreds of B2-SINE RNA molecules that drive nerve regeneration in mice. These ...

Scientists have produced a new roadmap outlining how genetic changes can affect the oil production of plants commonly used to ...

Women diagnosed with premenstrual symptoms have a slightly increased risk of developing cardiovascular disease later in life.

Scientists have discovered novel drug candidates that could ultimately lead to new effective treatments for conditions caused ...

The results offer real-world data that support long-term protection through vaccination and suggest a level of population ...

The FDA has released 200+ complete response letters in a bid to offer new insights into drug approval rejections and ...